By John Q. Hosedrinker 
A recent CDC report highlights a significant increase in kratom-related poisonings, which experts attribute to synthetic derivatives like 7-OH rather than natural kratom. This distinction is crucial, as natural kratom has been used for centuries for pain management and addiction recovery, with studies indicating its relative safety. Blanket bans on kratom, fueled by confusion with more potent synthetic compounds, risk harming individuals who rely on the natural plant for therapeutic benefits. While 7-OH poses risks similar to opioids, natural kratom’s unique pharmacological profile suggests it does not share the same dangers of respiratory depression and severe addiction.
Read the original article here
The United States is grappling with a concerning rise in reported kratom-related poisonings, a trend that experts largely attribute not to the natural plant itself, but to highly potent synthetic versions that have flooded the market. This surge in adverse events has ignited a debate about the future of kratom, with many advocating for nuanced regulation rather than outright bans, especially given the plant’s potential benefits for chronic pain sufferers and those seeking alternatives to opioids.
For centuries, the practice of consuming kratom, a tropical tree native to Southeast Asia, involved simply chewing its leaves, a method widely considered safe and effective for generations. The plant’s leaves contain compounds like mitragynine and 7-hydroxymitragynine (7-OH), which interact with opioid receptors in the brain, offering pain relief and mood elevation. Historically, this natural consumption allowed individuals to manage pain and other ailments without the severe risks associated with synthesized drugs.
However, the landscape has dramatically shifted with the proliferation of highly concentrated extracts and entirely synthetic derivatives, often marketed with exaggerated potency claims like “20x effect” or referencing potent compounds like 7-OH. These products, frequently found in gas stations and convenience stores, are a stark departure from the traditional use of the plain leaf. It’s this adulterated or synthetic form that is increasingly linked to the alarming reports of “poisonings” and calls to poison control centers.
Many individuals who rely on kratom for legitimate medical reasons, such as managing chronic pain, express deep concern over potential bans. One individual shared the experience of a family member who underwent extensive spinal surgery and lives with constant pain, finding relief through a decade-long regimen of alternating prescribed opioids with kratom. This approach has allowed them to manage their pain without becoming entirely dependent on powerful narcotics, highlighting kratom’s role as a harm-reduction tool for pain management.
The consensus among those who use kratom responsibly is that the problems arise from synthesized versions and extreme extracts, not the plant’s natural leaf powder. The distinction is often likened to the difference between chewing coca leaves and snorting refined cocaine – fundamentally different substances with vastly different risk profiles. A blanket ban, they argue, would penalize responsible users and potentially drive individuals seeking relief back to more dangerous, illicit substances.
Indeed, many users report that plain leaf kratom has been significantly more helpful for them than pharmaceutical opioids, with fewer addictive qualities and side effects. Some recount using it recreationally in the past without experiencing addiction or significant issues, only stopping due to the inconvenience of its preparation. This perspective underscores the notion that prohibition rarely addresses the root cause of problems, and that regulation, with clear labeling and standards, might be a more effective approach.
The core issue, as many see it, is the synthetic adulteration and the dangerous extracts, particularly 7-OH, which have tainted the reputation of plain leaf kratom. Those who advocate for distinguishing between the two emphasize that banning plain leaf kratom would be akin to banning coffee or alcohol, citing the hypocrisy of allowing these substances while potentially outlawing a plant that offers significant benefits to many.
For individuals dealing with chronic pain, plain leaf kratom powder has been a lifesaver, enabling them to function, work, and care for themselves when prescribed pain medications are insufficient or inconsistently available. While not as potent as narcotics, it provides a workable level of relief that allows them to maintain their daily lives. The concern is that the fear-mongering around the dangerous extracts will lead to a ban that negatively impacts those who depend on the natural plant.
Anecdotal experiences with the more potent products paint a starkly different picture. One individual described a terrifying experience of severe anxiety, sweating, and feeling on the verge of collapse after consuming a concentrated kratom product mixed into coffee, illustrating the unpredictable and dangerous nature of these super-charged versions. The presence of these products, sometimes even mixed with benzodiazepines and sold as energy drinks, further exacerbates the problem.
The vast majority of negative press surrounding kratom is seen as either misinformation or a misrepresentation of people combining it with other substances or using dangerous, modified forms. While acknowledging that kratom can be habit-forming, many users assert it is significantly less dangerous than alcohol, cannabis, or even some over-the-counter medications, likening its risk profile more closely to that of coffee.
A common theme is the observation that a pattern of leaving a substance completely unregulated, then reacting with alarm to dangerous variants, often leads to overcorrection in the form of bans. Experts suggest that establishing basic standards, clear labeling, and implementing regulations before resorting to prohibition would be a more constructive path.
The distinction between physical dependence and addiction is also frequently raised, with many long-term users reporting experiencing neither. For individuals with chronic pain who struggle to obtain adequate prescriptions, plain leaf kratom has been a vital tool for maintaining function and independence. The fear that extracts and potent derivatives will ruin it for those who genuinely need the natural plant is palpable.
When it comes to adverse events, some users advocate for “overdose” as a more accurate term than “poisoning.” They emphasize that their experience with purity-tested, natural kratom powder over many years has yielded benefits such as reduced anxiety and decreased alcohol cravings, with no detrimental effects on their health markers.
There is a strong sentiment that age restrictions, purity testing, and a prohibition on extracts are reasonable measures. However, the notion that kratom is excessively addictive and easily accessible is also acknowledged, with some comparing it to the issues seen with “spice” or synthetic cannabinoids. Yet, they also point out that the body’s natural aversion to excessive consumption, often manifesting as vomiting, serves as a built-in deterrent for plain leaf kratom.
The calls to poison control are often framed as seeking information rather than reporting a medical emergency, a crucial distinction often lost in the narrative. The argument is made that banning extracts and 7-OH is necessary to prevent a surge in overdoses, drawing parallels to the devastating consequences of the opioid epidemic crackdown. When safe alternatives are removed, individuals often turn to far less safe options.
The synthetic 7-OH is singled out as particularly problematic, described as having a much lower risk of fatal overdose due to less respiratory depression and a ceiling effect, but still posing addiction risks. The concern is that companies are synthesizing compounds found in trace amounts in kratom leaves and marketing them as superior or pure kratom, leading to these adverse events and prompting calls for blanket bans that would harm responsible users.
The unregulated nature of these products, particularly their availability in gas stations and convenience stores, is a significant concern. While many are supportive of the natural, plain leaf form of kratom, they believe the highly concentrated and synthetically altered versions require stringent regulation, if not outright prohibition.
The notion that the “war on pain patients” contributed to the rise in overdose deaths due to the opioid crisis is also brought up, suggesting that restricting access to kratom, a perceived “off-ramp” from harder drugs, could have similar dire consequences. Some argue that 7-OH, while addictive, offers a harm-reduction benefit by preventing users from turning to more dangerous substances like fentanyl, potentially saving lives and reducing the appeal of illicit drug markets.
The idea of regulating kratom through established channels, similar to how pharmaceuticals are handled, is proposed. Some recall seeing entire warehouse racks of 7-OH tablets being sold, with customers spending significant amounts of money, highlighting the commercial drive behind these potent products.
The fear-mongering surrounding kratom is viewed by some as unwarranted, particularly regarding claims of fatal overdoses. They argue that many reported deaths are often of individuals with polydrug addictions or natural causes, rather than a direct result of kratom alone. The comparison to alcohol and Tylenol, which can be harmful in excess but are legal, is frequently made.
The lack of regulation for sketchy, contaminated extracts sold for an extended period is seen as a failure of regulatory bodies. There’s a suspicion that regulators might even welcome these issues as a justification for future bans, even when the problems stem from products unrelated to the natural plant.
Some argue that 7-OH has a place in harm reduction, suggesting that its presence has coincided with decreasing overdose deaths from more dangerous opioids. While acknowledging the addiction potential, they believe 7-OH offers a safer alternative to substances like heroin and fentanyl, providing a path away from severe addiction.
The recurring theme of Western civilization’s tendency to “mess up something natural” by synthesizing or adulterating it is evident. The call is for a clear distinction between the natural plant and its synthetic counterparts, urging for the regulation or banning of the latter while preserving the former for its therapeutic potential.
The sheer intensity of some marketed products, like “EUPHORIA 140X STRENGTH,” is seen as a clear indicator that these are not being sought for health benefits but for a potent psychoactive effect, further justifying regulatory intervention for these specific formulations.
Ultimately, while kratom is acknowledged as a substance that can be addictive and have withdrawal symptoms, many believe it can be used responsibly and offers significant benefits. The current crisis is seen not as an indictment of kratom itself, but as a consequence of unregulated markets flooded with dangerous, synthesized derivatives. The hope is for a balanced approach that prioritizes regulation and consumer safety without resorting to blanket bans that could harm those who rely on natural kratom for pain relief and recovery.